{
    "id": 32568,
    "fullName": "PPM1D S432fs",
    "impact": "frameshift",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PPM1D S432fs results in a change in the amino acid sequence of the Ppm1d protein beginning at aa 432 of 605, likely resulting in premature truncation of the functional protein (UniProt.org). S432fs has been identified in the scientific literature (PMID: 31439867), but has not been biochemically characterized and therefore, its effect on Ppm1d protein function is unknown (PubMed, Feb 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 17806,
                    "pubMedId": 31439867,
                    "title": "PPM1D mutations silence NAPRT gene\u00a0expression and confer NAMPT inhibitor sensitivity in glioma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31439867"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8493,
        "geneSymbol": "PPM1D",
        "terms": [
            "PPM1D",
            "IDDGIP",
            "JDVS",
            "PP2C-DELTA",
            "WIP1"
        ]
    },
    "variant": "S432fs",
    "createDate": "02/11/2020",
    "updateDate": "02/11/2020",
    "referenceTranscriptCoordinates": {
        "id": 187909,
        "transcript": "NM_003620",
        "gDna": "chr17:g.(60663027_60663028)",
        "cDna": "c.(1294_1293)",
        "protein": "p.S432fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20331,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, FK866 treatment inhibited viability of a patient-derived diffuse intrinsic pontine glioma cell line harboring PPM1D P432fs in culture (PMID: 31439867).",
            "molecularProfile": {
                "id": 35114,
                "profileName": "PPM1D S432fs"
            },
            "therapy": {
                "id": 5662,
                "therapyName": "FK866",
                "synonyms": null
            },
            "indication": {
                "id": 4202,
                "name": "brain stem glioma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17806,
                    "pubMedId": 31439867,
                    "title": "PPM1D mutations silence NAPRT gene\u00a0expression and confer NAMPT inhibitor sensitivity in glioma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31439867"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35114,
            "profileName": "PPM1D S432fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 187909,
            "transcript": "NM_003620",
            "gDna": "chr17:g.(60663027_60663028)",
            "cDna": "c.(1294_1293)",
            "protein": "p.S432fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}